KemPharm, Inc. KMPH

Set alert

Price alert · KMPH

All alert types
5.81 0.00 0.00%

At close · Feb 28

5.79 Day range 5.97

52-week range unavailable

Open
5.83
Prev close
5.81
Mkt cap
200.47M
Vol
64.13K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
5.79
High
5.97
Forward P/E
-8.54
Beta
2.16
Short ratio
5.87
Inst. own
17.69%
Dividend
0.00
Ex-div date
Earnings
Mar 7, 2023
50-d avg
5.33
200-d avg
5.27
1y target
22.33

5m chart

Chart tools
Interval

Chart is warming up

The five-minute interval price history for KMPH has not been loaded yet. Try again in a moment.

Analyst view

Consensus: buy

Buy
Price target (mean) 22.33 +284.3% upside
Target (low)
19.00
Target (mean)
22.33
Target (high)
28.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
  • Strong buy2
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 3
  • 2 months ago 3
  • 3 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

KMPH analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.17-0.19 – -0.14-0.08-112.5%3.20M+23.9%3
Next quarter-0.15-0.15 – -0.15-0.05-200.0%3.90M-1.6%1
Current year-1.10-1.13 – -1.04-0.29-279.3%11.33M-60.5%3
Next year-0.68-1.10 – -0.37-1.10+38.2%18.40M+62.4%3

Upgrades and downgrades

The latest rating changes

KMPH analyst upgrades and downgrades
DateFirmActionFromTo
Nov 17, 2022Cantor FitzgeraldInitiated—Overweight
Sep 15, 2022Canaccord GenuityInitiated—Buy
Aug 17, 2022HC Wainwright & Co.Maintained—Buy
Jan 31, 2022HC Wainwright & Co.UpgradeNeutralBuy
Apr 9, 2021HC Wainwright & Co.Maintained—Neutral
Mar 4, 2021HC Wainwright & Co.DowngradeBuyNeutral
Jan 25, 2021Roth CapitalInitiated—Buy
May 20, 2020HC Wainwright & Co.Reiterated—Buy
Nov 20, 2019H.C. WainwrightReiterated—Buy
Sep 5, 2019Roth CapitalDowngradeBuyNeutral
Jun 19, 2019H.C. WainwrightInitiated—Buy
May 23, 2018Janney CapitalInitiated—Buy
Feb 26, 2018Canaccord GenuityMaintainedBuyBuy
Sep 18, 2015OppenheimerMaintained—Outperform
Jul 2, 2015Canaccord GenuityMaintained—Buy
Jun 15, 2015Canaccord GenuityMaintained—Buy
May 11, 2015OppenheimerInitiated—Outperform
May 11, 2015RBC CapitalInitiated—Outperform